Vectech Pharmaceutical Consultants is categorized under in Farmington, MI and active since 1978.
Vectech Pharmaceutical Consultants was established in 1978, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 325412 by the NAICS.
If you are seeking more information, feel free to contact Allan F Pfitzenmaier at the company’s headquarters by writing to 26105 Orchard Lake Road # 311, Farmington, Michigan MI 48334 or by phoning (248) 478-5820. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Vectech Pharmaceutical Consultants |
| Contact Person: | Allan F Pfitzenmaier |
| Address: | 26105 Orchard Lake Road # 311, Farmington, Michigan 48334 |
| Phone Number: | (248) 478-5820 |
| Website Address: | vectech.com |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 1978 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B & B2C |
| Business Category: | |
| SIC Code: | 2834 |
| NAICS Code: | 325412 |
| Share This Business: |
Vectech Pharmaceutical Consultants was started in 1978 to provide professional under the SIC code 2834 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Allan F Pfitzenmaier for inquiries that concern Vectech Pharmaceutical Consultants by calling the company number (248) 478-5820, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Vectech Pharmaceutical Consultants can be found at the coordinates 42.4853,-83.35826 as well as the street address 26105 Orchard Lake Road # 311 in Farmington, Michigan 48334.
For its online presence, you may visit Vectech Pharmaceutical Consultants’s website at vectech.com and engage with its social media outlets through on Twitter and on Facebook.